Skip to main content

D. E. Shaw & Co., Inc.

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1009207 New York, NY

Position in ANIP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,464,314
-$1,948,683 QoQ
Shares Held
174,732
-18.1% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 305 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. ANIP ranks #14 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIP

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,464,314 174,732
2026-03-31 $16,412,997 213,433
2025-12-31 $20,014,131 253,536
2025-09-30 $19,511,349 213,006
2025-06-30 $4,456,053 68,292
2025-03-31 $15,378,481 229,701
2024-12-31 $10,852,514 196,319
2024-09-30 $6,480,328 108,621
2024-06-30 $557,836 8,760
2022-03-31 $411,895 14,653
2021-12-31 $1,656,069 35,939
2021-09-30 $574,842 17,515
2021-06-30 $873,235 24,914
2021-03-31 $1,400,280 38,746
2020-12-31 $768,398 26,460
2020-03-31 $673,147 16,523